{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:21:52Z","timestamp":1793308912906,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.phymed.2024.155693","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T16:25:39Z","timestamp":1715099139000},"page":"155693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Bruceine A alleviates alcoholic liver disease by inhibiting AIM2 inflammasome activation via activating FXR"],"prefix":"10.1016","volume":"130","author":[{"given":"Lin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangning","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-0719","authenticated-orcid":false,"given":"Qiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.phymed.2024.155693_bib0001","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jhep.2023.07.034","article-title":"FXR agonists in NASH treatment","volume":"79","author":"Adorini","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2024.155693_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1225821","article-title":"The effect of liver disease on hepatic microenvironment and implications for immune therapy","volume":"14","author":"Brown","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.phymed.2024.155693_bib0003","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/exd.14711","article-title":"Neutrophil extracellular traps promote keratinocyte inflammation via AIM2 inflammasome and AIM2-XIAP in psoriasis","volume":"32","author":"Cao","year":"2023","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.phymed.2024.155693_bib0004","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.apsb.2022.06.015","article-title":"viaMelatonin alleviates alcoholic liver disease EGFR-BRG1-TERT axis regulation","volume":"13","author":"Che","year":"2023","journal-title":"Acta Pharm. Sin. B."},{"issue":"5","key":"10.1016\/j.phymed.2024.155693_bib0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cld.1061","article-title":"Global epidemiology of chronic liver disease","volume":"17","author":"Cheemerla","year":"2021","journal-title":"Clin. Liver Dis."},{"issue":"4","key":"10.1016\/j.phymed.2024.155693_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.152875","article-title":"The hepatoprotective effects of XCHD and MgIG against methotrexate-induced liver injury and inflammation in rats through suppressing the activation of AIM2 inflammasomes","volume":"216","author":"Chen","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.phymed.2024.155693_bib0007","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/JS9.0000000000000127","article-title":"Repurposing of Mycobacterium leprae for liver regeneration: an update","volume":"109","author":"Chopra","year":"2023","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.phymed.2024.155693_bib0008","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1124\/jpet.105.097758","article-title":"Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor","volume":"317","author":"Deng","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phymed.2024.155693_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104714","article-title":"Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases","volume":"94","author":"Dewidar","year":"2023","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.phymed.2024.155693_bib0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cld.2016.02.004","article-title":"Pathogenesis of alcoholic liver disease","volume":"20","author":"Dunn","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.phymed.2024.155693_bib0011","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/liv.13642","article-title":"Ethanol-mediated suppression of IL-37 licenses alcoholic liver disease","volume":"38","author":"Grabherr","year":"2018","journal-title":"Liver Int"},{"issue":"24","key":"10.1016\/j.phymed.2024.155693_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27248968","article-title":"Natural product 2-oxokolavenol is a novel FXR agonist","volume":"27","author":"Guo","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.phymed.2024.155693_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032408","article-title":"Role of FXR in renal physiology and kidney diseases","volume":"24","author":"Guo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phymed.2024.155693_bib0014","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/gutjnl-2021-324727","article-title":"Clomethiazole inhibits cytochrome P450 2E1 and improves alcoholic liver disease","volume":"71","author":"Hohmann","year":"2022","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.phymed.2024.155693_bib0015","first-page":"670","article-title":"Puerarin inhibits inflammation and lipid accumulation in alcoholic liver disease through regulating MMP8. Chin","volume":"21","author":"Hu","year":"2023","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.phymed.2024.155693_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115640","article-title":"Biotransformed bear bile powder ameliorates diet-induced nonalcoholic steatohepatitis in mice through modulating arginine biosynthesis via FXR\/PXR-PI3K-AKT-NOS3 axis","volume":"168","author":"Jiang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2024.155693_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153629","article-title":"Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR","volume":"90","author":"Kong","year":"2021","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.phymed.2024.155693_bib0018","doi-asserted-by":"crossref","first-page":"16339","DOI":"10.1111\/jcmm.16339","article-title":"FXR-mediated epigenetic regulation of GLP-1R expression contributes to enhanced incretin effect in diabetes after RYGB","volume":"28","author":"Kong","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"15","key":"10.1016\/j.phymed.2024.155693_bib0019","doi-asserted-by":"crossref","first-page":"8518","DOI":"10.1111\/jcmm.15473","article-title":"Salvianic acid A alleviates chronic alcoholic liver disease by inhibiting HMGB1 translocation via down-regulating BRD4","volume":"24","author":"Lan","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.phymed.2024.155693_bib0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.kint.2022.04.020","article-title":"Bruceine A protects against diabetic kidney disease via inhibiting galectin-1","volume":"102","author":"Li","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.phymed.2024.155693_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126317","article-title":"Effect of natural polysaccharides on alcoholic liver disease: a review","volume":"251","author":"Li","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phymed.2024.155693_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102559","article-title":"RAGE promotes dysregulation of iron and lipid metabolism in alcoholic liver disease","volume":"59","author":"Li","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.phymed.2024.155693_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104543","article-title":"Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease","volume":"90","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phymed.2024.155693_bib0024","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1016\/j.csbj.2021.06.011","article-title":"A novel P38\u03b1 MAPK activator Bruceine A exhibits potent anti-pancreatic cancer activity","volume":"19","author":"Lu","year":"2021","journal-title":"Comp. Struct. Biotechnol. J."},{"issue":"11","key":"10.1016\/j.phymed.2024.155693_bib0025","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1007\/s11095-015-1727-x","article-title":"Protective effects of alisol B 23-acetate via farnesoid X receptor-mediated regulation of transporters and enzymes in estrogen-induced cholestatic liver injury in mice","volume":"32","author":"Meng","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phymed.2024.155693_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1212742","article-title":"Harnessing the potential of probiotics in the treatment of alcoholic liver disorders","volume":"14","author":"Mishra","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155693_bib0027","article-title":"Metabolic role of the hepatic valine\/3-hydroxyisobutyrate (3-HIB) pathway in fatty liver disease","volume":"91","author":"Mona Synn\u00f8ve","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phymed.2024.155693_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116331","article-title":"Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist","volume":"173","author":"Moon","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2024.155693_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119328","article-title":"A review on molecular mechanism of alcoholic liver disease","volume":"274","author":"Namachivayam","year":"2021","journal-title":"Life Sci."},{"issue":"24","key":"10.1016\/j.phymed.2024.155693_bib0030","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.21037\/atm-22-5010","article-title":"Diagnostic significance of serum type IV collagen (IVC) combined with aspartate aminotransferase (AST)\/alanine aminotransferase (ALT) ratio in liver fibrosis","volume":"10","author":"Niu","year":"2022","journal-title":"Ann. Transl. Med."},{"issue":"7","key":"10.1016\/j.phymed.2024.155693_bib0031","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12272-022-01392-4","article-title":"Alcoholic liver disease: a new insight into the pathogenesis of liver disease","volume":"45","author":"Park","year":"2022","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.phymed.2024.155693_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174841","article-title":"Inonotus obliquus and its bioactive compounds alleviate non-alcoholic fatty liver disease via regulating FXR\/SHP\/SREBP-1c axis","volume":"921","author":"Peng","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155693_bib0033","article-title":"Prunella vulgaris L. attenuates gut dysbiosis and endotoxin leakage against alcoholic liver disease","volume":"319","author":"Rao","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.phymed.2024.155693_bib0034","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2016.03.046","article-title":"Inflammasome complexes: emerging mechanisms and effector functions","volume":"165","author":"Rathinam","year":"2016","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.phymed.2024.155693_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12071425","article-title":"Autophagy, oxidative stress, and alcoholic liver disease: a systematic review and potential clinical applications","volume":"12","author":"Salete-Granado","year":"2023","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.phymed.2024.155693_bib0036","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4103\/0976-0105.105339","article-title":"A study of the prevalence of thalassemia and its correlation with liver function test in different age and sex group in the Chittagong district of Bangladesh","volume":"3","author":"Sarmi","year":"2012","journal-title":"J Basic Clin Pharm"},{"issue":"1","key":"10.1016\/j.phymed.2024.155693_bib0037","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.phymed.2024.155693_bib0038","article-title":"Clinical efficacy of probiotics in the treatment of alcoholic liver disease: a systematic review and meta-analysis","volume":"14","author":"Shi-Ying","year":"2024","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.phymed.2024.155693_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121720","article-title":"Endoplasmic reticulum-targeted inhibition of CYP2E1 with vitamin E nanoemulsions alleviates hepatocyte oxidative stress and reverses alcoholic liver disease","volume":"288","author":"Shi","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.phymed.2024.155693_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1135952","article-title":"The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR\/FXR dual receptor activator","volume":"14","author":"Shiragannavar","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phymed.2024.155693_bib0041","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG Clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.phymed.2024.155693_bib0042","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/08916934.2022.2103802","article-title":"AIM2-inflammasome role in systemic lupus erythematous and rheumatoid arthritis","volume":"55","author":"Uresti-Rivera","year":"2022","journal-title":"Autoimmunity"},{"key":"10.1016\/j.phymed.2024.155693_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128394","article-title":"The gut-liver axis perspective: exploring the protective potential of polysaccharides from Cistanche deserticola against alcoholic liver disease","volume":"256","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phymed.2024.155693_bib0044","article-title":"Roles of AIM2 GENE and AIM2 inflammasome in the pathogenesis and treatment of psoriasis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.phymed.2024.155693_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153845","article-title":"Isoliquiritigenin-mediated miR-23a-3p inhibition activates PGC-1\u03b1 to alleviate alcoholic liver injury","volume":"96","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2024.155693_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102322","article-title":"Overexpression of NAG-1\/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation","volume":"52","author":"Wang","year":"2022","journal-title":"Redox Biol"},{"issue":"9","key":"10.1016\/j.phymed.2024.155693_bib0047","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1016\/j.apsb.2023.01.009","article-title":"in vivoAmelioration of ethanol-induced oxidative stress and alcoholic liver disease by RNAi targeting","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.phymed.2024.155693_bib0048","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1042\/CS20211075","article-title":"AIM2 inflammasome contributes to aldosterone-induced renal injury via endoplasmic reticulum stress","volume":"136","author":"Wu","year":"2022","journal-title":"Clin. Sci."},{"issue":"6","key":"10.1016\/j.phymed.2024.155693_bib0049","doi-asserted-by":"crossref","first-page":"G1034","DOI":"10.1152\/ajpgi.00431.2020","article-title":"Mitochondrial DNA enables AIM2 inflammasome activation and hepatocyte pyroptosis in nonalcoholic fatty liver disease","volume":"320","author":"Xu","year":"2021","journal-title":"Am. J. Physiol.-Gastroint. Liver Physiol."},{"issue":"1","key":"10.1016\/j.phymed.2024.155693_bib0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12967-023-04166-8","article-title":"Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease","volume":"21","author":"Yan","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phymed.2024.155693_bib0051","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.2147\/JIR.S392652","article-title":"The role of AIM2 inflammasome in knee osteoarthritis","volume":"15","author":"Yang","year":"2022","journal-title":"J. Inflamm. Res."},{"issue":"13","key":"10.1016\/j.phymed.2024.155693_bib0052","doi-asserted-by":"crossref","DOI":"10.3390\/foods12132492","article-title":"Ginsenoside Rh4 improves hepatic lipid metabolism and inflammation in a Model of NAFLD by targeting the gut liver axis and modulating the FXR signaling pathway","volume":"12","author":"Yang","year":"2023","journal-title":"Foods"},{"key":"10.1016\/j.phymed.2024.155693_bib0053","article-title":"Bruceine a exerts antitumor effect against colon cancer by accumulating ROS and suppressing PI3K\/Akt pathway","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.phymed.2024.155693_bib0054","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/hep.29878","article-title":"The hepatic BMAL1\/AKT\/lipogenesis axis protects against alcoholic liver disease in mice via promoting PPAR\u03b1 pathway","volume":"68","author":"Zhang","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.phymed.2024.155693_bib0055","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.dld.2018.04.009","article-title":"FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice","volume":"50","author":"Zhang","year":"2018","journal-title":"Digest Liver Dis"},{"issue":"6","key":"10.1016\/j.phymed.2024.155693_bib0056","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11061211","article-title":"The beneficial effects of natural extracts and bioactive compounds on the gut-liver axis: a promising intervention for alcoholic liver disease","volume":"11","author":"Zhao","year":"2022","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.phymed.2024.155693_bib0057","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10565-022-09737-x","article-title":"Baohuoside I inhibits FXR signaling pathway to interfere with bile acid homeostasis via targeting ER \u03b1 degradation","volume":"39","author":"Zhao","year":"2023","journal-title":"Cell Biol. Toxicol."},{"issue":"5","key":"10.1016\/j.phymed.2024.155693_bib0058","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s43657-021-00033-y","article-title":"Phenome-wide association analysis reveals novel links between genetically determined levels of liver enzymes and disease phenotypes","volume":"2","author":"Zhenqiu","year":"2022","journal-title":"Phenomics"},{"key":"10.1016\/j.phymed.2024.155693_bib0059","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1050774","article-title":"AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324003520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324003520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T01:18:06Z","timestamp":1717463886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324003520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":59,"alternative-id":["S0944711324003520"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155693","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bruceine A alleviates alcoholic liver disease by inhibiting AIM2 inflammasome activation via activating FXR","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155693"}}